Effect of preoperative low-dose esketamine versus dexmedetomidine nasal drip on delirium during awakening in children undergoing fibrinoscopy: a prospective randomized controlled trial

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073087

Enrollment

Unknown

Registered

2023-06-30

Start date

2023-01-20

Completion date

Unknown

Last updated

2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium during awakening in children

Interventions

Group K:Esketamine

Group D :Dexmedetomidine

Group C:normal saline

Eligibility

Sex/Gender

All

Age

1 Years to 6 Years

Inclusion criteria

Inclusion criteria: ?Children aged 1-6 years old who were selected for elective fibrinoscopy in our hospital ? ASA I~II ?Normal development ?Sign the informed consent form

Exclusion criteria

Exclusion criteria: ?Premature infants, abnormal developmental delays ?Epilepsy, altered state of consciousness, abnormal neurological function ?heart, liver, kidney dysfunction, moderate to severe anemia, cranio-cerebral disease and increased intracranial pressure ?Ward sedation treatment

Design outcomes

Primary

Measure	Time frame
Cornell Assessment of Pediatric Delirium(CAPD); Face, Legs, Activity, Cry, Consolability (FLACC) ;Awakening time;	—

Secondary

Measure	Time frame
The dwell time of PACU ;Operation time;	—

Countries

China

Contacts

Public ContactWei Xie

Foshan Maternal &Child Health Hospital

xiewei84327426@qq.com13794037407

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026